(Q40432509)

20 September 2017

title

Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis (English)

1 reference

20 September 2017

5

1 reference

20 September 2017

Sanda T

1

1 reference

20 September 2017

Kuwano T

2

1 reference

20 September 2017

Nakao S

3

1 reference

20 September 2017

Iida S

4

1 reference

20 September 2017

Komatsu H

6

1 reference

20 September 2017

Shudo K

7

1 reference

20 September 2017

Kuwano M

8

1 reference

20 September 2017

Ono M

9

1 reference

20 September 2017

Ueda R

10

1 reference

20 September 2017

publication date

1 June 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

19

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

901-909

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403754

20 September 2017

exact match

0 references

cites work

Multistep Tumorigenesis of Multiple Myeloma: Its Molecular Delineation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Inhibition of IL-1-induced IL-6 production by synthetic retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

inferred from DOI database lookup

7 January 2021

based on heuristic

Angiogenesis in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of ornithine decarboxylase induction by retinobenzoic acids in relation to their binding affinities to cellular retinoid-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403754

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403754

1 reference

Dimensions Publication ID

20 September 2017

1011918258

0 references

1 reference